AstraZeneca is leaving no stone unturned in its effort to make baxdrostat the first aldosterone synthase inhibitor (ASI) to get approval for hard-to-treat hypertension. The FDA has now started a ...

Jeff Carlson writes about mobile technology for CNET. He is also the author of dozens of how-to books covering a wide spectrum ranging from Apple devices and cameras to photo editing software and ...

AI agents are popping up everywhere, but without a conductor, they clash, waste money and create more problems than they solve. By early 2026, the novelty phase of AI agents has officially ended and ...

Zoho Social offers affordable social media scheduling, analytics, AI-powered content tools, and seamless integration across the broader Zoho suite.

Don’t start with moon shots. by Thomas H. Davenport and Rajeev Ronanki In 2013, the MD Anderson Cancer Center launched a “moon shot” project: diagnose and recommend treatment plans for certain forms ...